Background: Prednisone is a corticosteroid used in several inflammatory diseases and cancers. In France, no available prednisone drinkable formulation exists. Instead, an oral syrup of prednisone with ethanol, sodium benzoate and simple syrup is produced. However, sodium benzoate can induce neonatal icterus and alcohol is not authorized for children below 3 years of age. The aim of this study was to determine the stability of 5 mg/mL prednisone oral suspension in a commercial compounding excipient: Syrspend ® SF PH4.
Introduction
Prednisone (Figure 1 ) is a glucocorticosteroid usually used in several inflammatory pathologies and cancers. Low dose prednisone is used for anti-inflammatory activities, while high dose prednisone is employed for immunosuppressive purposes [1] .
This drug is usually used in pediatric oncology and hematology units. To facilitate the pediatric use, drinkable formulations of prednisone are preferred over oral solid forms. However, no available prednisone drinkable formulation exists (no commercial syrup or ATU: Temporary Authorization for Use) in France and only tablets of prednisone are available [1] .
Despite this, a few studies on liquid oral formulations have been reported [2, 3] . For several years, an oral syrup of prednisone with alcohol (ethanol), sodium benzoate, and simple syrup [4] was prepared in our hospital. The stability of this preparation was maintained for 56 days under refrigeration ( + 2°C + 8°C) in amber glass vials. However, alcohol is not recommended for use in pediatric therapeutics or is used at a percentage of less than 5 % [5] . Moreover, sodium benzoate can induce neonatal icterus [6] .
To avoid these excipients with known effects, we decided to rely on a commercial compounding vehicle: Syrspend ® SF PH4, a product that is frequently used in oral suspension drugs. Many studies have approved the compatibility between active pharmaceutical ingredients (API) and this vehicle [7, 8] . Furthermore, the stability of prednisolone suspension ( Figure 2 ) in Syrspend ® SF PH4 was studied [8] ,
while it remains unknown for prednisone.
Materials and methods

Analytical method Reagents
Micronized prednisone was bought to Inresa (Bartenheim, France) and Syrspend ® SF PH4 to Fagron (Thiais, France). Methanol was of HPLC grade and was purchased from VWR Chemicals (Fontenay-sous-Bois, France). Prednisone and prednisolone standards were procured from Merck (Darmstadt, Germany). Water for HPLC was distilled and passed through a reverse osmosis system. Hydrochloric acid (HCl) solutions 0.1 M and 1 M were purchased from VWR Chemicals (Fontenay-sous-Bois, France), sodium hydroxide (NaOH) 0.1 M and 1 M were bought to Merck (Darmstadt, Germany), oxygen peroxide (H 2 O 2 ) 10 volumes was acquired from Gifrer (Decines-Charpieu, France).
Instrumentation and chromatographic conditions
The HPLC system included a 717 plus autosampler, 2487 UV detector, and a HPLC 515 pump (Waters, Milford, USA). Chromatographic separation of the analytes was carried out on Waters Xterra RP C18 5 µm column (4.6*150 mm). The volume injection of the sample was 10 µL. The flow rate was kept at 1 mL/min and prednisone was detected at 254 nm [9, 10] . The oven temperature was kept at 45 degrees Celsius.
Multiple mobile phases were tested to achieve an optimal elution. Fourteen different combinations of organic solvent and water were tried: acetonitrile/water, acetonitrile/methanol/water and methanol/water, each at various proportions.
Data were acquired and processed with EMPOWER Software (Warers, Milford, USA). All calculations were performed using Microsoft Excel 2010 (Microsoft Corporation, USA).
Preparation of oral suspensions
Three batches of 5 mg/mL oral suspension were prepared, using 350 mg of micronized prednisone and 70 mL of Syrspend ® SF PH4. These were packaged in amber glass vials (60 mL) to protect from light and stored at room temperature throughout the study. According to the European Pharmacopoeia [11] , prednisone could be protected from light. That why, the study was realized with amber glass. Prednisone concentrations were determined on days 0, 1, 4, 10, 30, 60, 90 after the first day of production.
Method parameters validation
The HPLC method was validated according to the International Conference on Harmonization (ICH) guidelines (Q2R1) [12] including the assessment of system linearity, accuracy, precision (repeatability, intermediate precision) and specificity [13] .
Standard stock solutions of prednisone were prepared in methanol to obtain a concentration of 5 mg/ mL. Six calibration curves were prepared using this solution. The work concentrations of calibration standards were 75 µg/mL, 100 µg/mL, 125 µg/mL, 150 µg/mL and 175 µg/mL and the work concentrations of the three quality controls (QC) were 75 µg/mL, 125 µg/mL and 175 µg/ mL. An assay range between 60 % and 140 % of the target value (125 µg/mL) was respected according to the ICH.
Linearity
The response function was performed on three different days with the six calibrations curves. In order to check whether an excipient effect existed, two types of ranges were produced: a range only containing the API and a reconstituted range, with Syrspend ® SF PH4. The method was considered as linear if the coefficient of determination was over 0.99 for the mean standard curve.
Accuracy
The accuracy was determined using the data obtained during study of the response function. For each QC, the accuracy was measured by calculating the report between theoretical and calculated concentrations. This report allows the access to a recovery rate, whereby, it had to be less than 5 % in order to be accepted.
Precision
To determine the repeatability of this method, six points of the middle of the range was performed (125 µg/mL), and each point was prepared by independent weighing. Then, the intermediate precision was determined on three different days, using the relative standard variation (RSD), which had to be less than 5 %.
Stability indicating method
A stability indicating method is a process that is able to distinguish the API from its degradation products. The method has to be sufficiently sensitive to detect these degradation products in low quantity and sufficiently resolute to distinguish products with potentially close structures [13, 14] . Forced degradation experiments were carried out on prednisone under various conditions explained in the ICH guideline: heat, acid, alkaline and oxidative conditions.
A thermal degradation study was performed at two different temperatures: room temperature (24°C ± 1°C) and 80°C in a water bath. The exposure time was one hour in both conditions. Acid hydrolysis was studied by adding HCl solutions at 0.1 M, 0.5 M and 1 M in prednisone solution. At one hour of exposure time, neutralization was performed with respectively 0.1 M, 0.5 M, and 1 M NaOH solutions. The alkaline hydrolysis was performed by doing the opposite procedure of acid hydrolysis (exposition with NaOH, then neutralization with HCl). Acid and alkaline degradation was performed in a water bath heated to 80°C, for one hour.
Oxidative degradation was assessed by exposed prednisone solution in 10 volumes of H 2 O 2 for three hours in a water bath heated to 100°C.
The degradation was confirmed if a reduction of more 5 % of prednisone concentration was observed.
Related substances
A solution of prednisolone was prepared in methanol to obtain a concentration of 5 mg/mL to differentiate prednisone to prednisolone. A work concentration of 125 µg/ mL of prednisolone was compared to the same concentration of prednisone solution by HPLC. The same analysis method was used for the two molecules.
The resolution between these two peaks had to be more than 1.5 to validate the separation.
Analysis during the studied period
Three prednisone oral suspensions were prepared at day 0. During each time of the study (days 0, 1, 4, 10, 30, 60, 90) physical and chemical parameters were observed on the three batches.
Visual and odour inspection
A visual inspection was done in order to detect precipitation or variation of colour with time. A control of odour suspension was also performed.
Osmolality
The osmolality of the suspension was measured with Advanced Instruments Model 3250 Osmometer (Radiometer, Neuilly-Plaisance, France). A 250 µL aliquot of each suspension were taken and diluted (1:2 v/v) in water for injection before measurement.
pH
The pH was determined with a pH-meter: pHenomenal VWR ® (VWR Chemicals, Fontenay-sous-Bois, France).
Measure of concentration
Prednisone concentration was quantified in triplicates immediately after preparation and after 1, 4, 10, 30, 60 and 90 days. Before removing samples, the containers were handshaken manually to ensure a homogeneous suspension, according to the 9th edition of the European Pharmacopoeia [11] . Then, 400 µL sample of each preparation was diluted (1:10 v/v) in methanol and centrifuged at 4000 rpm for five minutes to sediment insoluble excipients. 
Results
Analytical method
The chosen mobile phase has been composed of methanol/water (45:55 v/v).
Method parameters validation Linearity
The coefficients of determination were 0.9999, 0.9994 and 0.9998, for days 1, 2 and 3, respectively, in the suspension without Syrspend ® SF PH4. 
Accuracy
The accuracy rates for the 75 µg/mL, 125 µg/mL and 175 µg/mL QC were estimated to be 0.50 %, 0.59 % and 1.12 %, respectively. These results related to ranges with excipient.
Precision
This method is repeatable because of a RSD of 1.64 %, 2.16 % and 1.37 %, for days 1, 2 and 3, respectively. The results of the intermediate precision for three days showed a RSD of 1.72 %.
Stability indicating method
No degradation was observed at room temperature (20°C) (Figure 3 ) and heating at 80°C (Figure 4) .
The acid hydrolysis showed a reduction of prednisone concentration of 8. 2.00 3.00 4.00 5.00 6.00 7.00 8.00 9.00 10.00 11.00 12.00 13.00 14.00 15.00 Figure 3 : chromatogram of prednisone at room temperature.
The alkaline hydrolysis was observed with low concentration of NaOH. In fact, a reduction of 80 % of prednisone concentration was visible with NaOH 0.1 M (Figure 6 ). The same result was noted with 0.5 and 1 M of NaOH.
No variation was observed with H 2 O 2 (reduction of 4.5 %).
The prednisone degradation is poor in acid environment but major in basic environment. 
Related substances
The resolution between peaks of prednisone and prednisolone was calculated at 2.9 ( Figure 7 ).
Analysis during the studied period Visual and odour inspection
No precipitation, no variation of colour or odour on the suspension was observed in the three batches.
Osmolality
During the study period, all osmolality measurements were included between 42 and 46 mOsm/Kg (Table 1) . No significant variation of osmolality was observed.
pH During the study, all pH measurements were included between 4.18 and 4.22 (Table 1) . No significant variation of pH was observed.
Measure of concentration
After validation of the analytical method, prednisone concentrations remained stable within more or less 5 % of nominal value over 60 days. Two of the three batches showed a concentration more than 5 % of nominal value on the day 90 ( Table 2) . Results of the Shapiro-test showed that samples followed a normality test data (p-value = 0.9638). Student test did not show a significant difference from day 0 to day 60 (t calc < t table). However, a significant difference from the day 90 was observed (t calc = 5.3 and t table = 2.92).
Discussion
A suspension of prednisone dosing at 5 mg/mL in Syrspend ® SF PH4 was tested using a simple method:
high performance liquid chromatography (HPLC). After the fourteen tests, the mobile phase methanol/ water (45:55 v/v) seemed more efficient than the other mixtures: the retention time was optimal (approximately seven minutes) and the peak was optimal (tailing factor = 1.1). Other mixtures that could have been tested were various combinations of methanol/water/tetrahydrofuran [15, 16] .
The chemical structure of prednisone is similar to the prednisolone structure. The difference is the molecular Table 1 : pH and Osmolality values of prednisone in oral suspension. pH and Osmolality expressed as mean ± standard deviation (SD) of triplicate measurements of one test suspension (n = 3). chemical group on the Carbon number 12: an alcohol group is substituted by a ketone group in prednisolone. A chromatographic separation of prednisone and prednisolone confirmed that the retention time of these two molecules are different. The validation of the analytical method confirmed the use of this method to measure the concentration of prednisone with HPLC. A good linearity with a coefficient of determination constantly more than 0.999 was obtained. The accuracy and the precision rates were measured to be less than 5 %, suggesting that this method is highly repeatable. The stability indicating method has permitted to bring out degradation products of prednisone [13] .
The study of prednisone suspension in Syrspend ® SF PH4 showed a stability of 60 days. Any variation of pH measurement and osmolality measurement was observed. Concentrations of prednisone remained stable within more or less 5 % of nominal values over 60 days.
No degradation product was detected throughout the studied period. A variation of concentration is fixed to 5 % for drugs with narrow therapeutic window, and 10 % for other therapeutic [13] . Even if prednisone is not a drug with narrow therapeutic window, we preferred to secure the reduction of concentration to 5 % of the nominal values because this suspension is reserved for children.
The microbiological stability is recommended to show the conservation over time within limits for contamination (ie: germs, moulds, yeasts) as according to the European Pharmacopoeia [12, 14] . However, the microbiological stability of this suspension was not evaluated because of lake of materials in the laboratory.
Viscosity analysis is a limit of this study [13] . The friction force was not evaluated because no rotating viscometer was available in our laboratory.
Taken together, the results of this study showed that this new suspension is easier to produce than the syrup of prednisone with alcohol, sodium benzoate and simple syrup. Indeed, the fabrication time is shorter and the number of compounds is smaller.
Conclusion
This study showed that 5 mg/mL prednisone oral suspension in Syrspend ® SF PH4 was stable for 60 days, at room temperature and protected from light. This new suspension would provide an interesting alternative to the syrup with alcohol and sodium benzoate, especially for pediatric use.
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